Skip to content
★ Sign in to follow
PT

P Thomson

GlaxoSmithKline plc
Total declarations
65
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (2 ops.)
€1.2M

Latest filing published 13 May 2021 for GlaxoSmithKline plc, €281.

Filing timeline

BuySale
P Thomson

Insider track record

Disclosed buys
0
Disclosed sells
2
Signal history

P Thomson: trading record in brief

P Thomson discloses dealings in GlaxoSmithKline plc to RNS (LSE). Over a trading history stretching from 14 February 2018 to 12 May 2021, the count stands at 65 filings.

Every open-market trade on record is a sale: 2 sales worth €1.2M. Besides market trades, the filings include 62 share grants. 2021 to date brings no purchases and 1 sale.

On 13 May 2021 came the latest disclosure, a share grant for €281 in GlaxoSmithKline plc. The median gap between a trade and its publication by RNS (LSE) is 2 days. The legal deadline for notifying a trade is three business days (UK MAR). Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from RNS (LSE). Past trades are no guide to future returns.

Companies and markets linked to P Thomson

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations65 total
  • ◆
    President, Global AffairsExecutivesGlaxoSmithKline plc
    241 GBP0FCA-NSM
    18 shares@ £13.4072London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3974287-9
  • ◆
    President, Global AffairsExecutivesGlaxoSmithKline plc
    15,659 GBP0FCA-NSM
    1,209.107 shares@ £12.9508London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3944285-10
  • ◆
    President, Global AffairsExecutivesGlaxoSmithKline plc
    258 GBP0FCA-NSM
    20 shares@ £12.906London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3943193-9
  • ◆
    President, Global AffairsExecutivesGlaxoSmithKline plc
    5,194 GBP0FCA-NSM
    393 shares@ £13.216London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3943052-14
  • ◆
    President, Global AffairsExecutivesGlaxoSmithKline plc
    959 GBP0FCA-NSM
    73 shares@ £13.1367London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3938809-10
  • ◆
    President, Global AffairsExecutivesGlaxoSmithKline plc
    253 GBP0FCA-NSM
    20 shares@ £12.671London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3908301-9
  • ◆
    President, Global AffairsExecutivesGlaxoSmithKline plc
    0FCA-NSM
    9,555 sharesN/AISIN GB0009252882FCA-NSM:3897443-14
  • ▼
    President, Global AffairsExecutivesGlaxoSmithKline plc
    54,548 GBP0FCA-NSM
    4,507 shares@ £12.103N/AISIN GB0009252882FCA-NSM:3897443-15
  • ◆
    President, Global AffairsExecutivesGlaxoSmithKline plc
    0FCA-NSM
    31,041 sharesLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3882407-12
  • ◆
    President, Global AffairsExecutivesGlaxoSmithKline plc
    0FCA-NSM
    66,043 sharesN/AISIN GB0009252882FCA-NSM:3879317-13
  • ◆
    President, Global AffairsExecutivesGlaxoSmithKline plc
    0FCA-NSM
    5,709 sharesN/AISIN GB0009252882FCA-NSM:3878373-13
  • ◆
    President, Global AffairsExecutivesGlaxoSmithKline plc
    0FCA-NSM
    92,012 sharesN/AISIN GB0009252882FCA-NSM:3878367-14
  • ◆
    President, Global AffairsExecutivesGlaxoSmithKline plc
    254 GBP0FCA-NSM
    20 shares@ £12.717London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3875131-9
  • ◆
    President, Global AffairsExecutivesGlaxoSmithKline plc
    4,947 GBP0FCA-NSM
    355 shares@ £13.934London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3851939-14
  • ◆
    President, Global AffairsExecutivesGlaxoSmithKline plc
    6,201 GBP0FCA-NSM
    441.416 shares@ £14.0488London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3850615-10
  • ◆
    President, Global AffairsExecutivesGlaxoSmithKline plc
    249 GBP0FCA-NSM
    18 shares@ £13.8428London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3844188-9
  • ◆
    President, Global AffairsExecutivesGlaxoSmithKline plc
    252 GBP30FCA-NSM
    18 shares@ £14.0272100.0% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3811317-9
  • ◆
    President, Global AffairsExecutivesGlaxoSmithKline plc
    234 GBP0FCA-NSM
    16 shares@ £14.6231London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3777599-9
  • ◆
    President, Global AffairsExecutivesGlaxoSmithKline plc
    4,889 GBP0FCA-NSM
    343 shares@ £14.254London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3748390-14
  • ◆
    President, Global AffairsExecutivesGlaxoSmithKline plc
    6,121 GBP0FCA-NSM
    425.02 shares@ £14.4008London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3746934-12
  • ◆
    President, Global AffairsExecutivesGlaxoSmithKline plc
    259 GBP0FCA-NSM
    18 shares@ £14.3994London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3746905-9
  • ◆
    President, Global AffairsExecutivesGlaxoSmithKline plc
    243 GBP0FCA-NSM
    16 shares@ £15.2038London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3714306-9
  • ◆
    President, Global AffairsExecutivesGlaxoSmithKline plc
    256 GBP22FCA-NSM
    16 shares@ £15.97871.7% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3686982-9
  • ◆
    President, Global AffairsExecutivesGlaxoSmithKline plc
    4,810 GBP25FCA-NSM
    302 shares@ £15.92831.0% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3657059-14
  • ◆
    President, Global AffairsExecutivesGlaxoSmithKline plc
    6,048 GBP26FCA-NSM
    383.416 shares@ £15.773339.3% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3656063-12

25 of 65 declarations